Uses and abuses of genetic engineering

Postgraduate Medical Journal

Volumn 79, Issue 931, 2003, Pages 249-251

  Alexander, Denis R ^a,b  

^a BABRAHAM INSTITUTE   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALEFACEPT; DNA HYBRID; RECOMBINANT DNA;

ANALYTIC METHOD; COMBINED IMMUNODEFICIENCY; DIAGNOSTIC ERROR; DNA PROBE; DNA SEQUENCE; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG RECEPTOR BINDING; EDITORIAL; GENE EXPRESSION; GENE IDENTIFICATION; GENE TECHNOLOGY; GENE THERAPY; GENE TRANSFER; GENETIC DISORDER; GENETIC ENGINEERING; GENOME; HUMAN; MOLECULAR BIOLOGY; NIDATION; NONHUMAN; POINT MUTATION; PRENATAL DIAGNOSIS; PSORIASIS; SEQUENCE HOMOLOGY; SEX DETERMINATION; TREATMENT OUTCOME;

EID: 0037972260     PISSN: 00325473     EISSN: None     Source Type: Journal    
DOI: 10.1136/pmj.79.931.249     Document Type: Editorial

References (13)

1. Consortium MGS. Initial sequencing and comparative analysis of the mouse genome. Nature 2002;420:520-62.
2. Huettner CS, Zhang P, Van Etten RA, et al. Reversibility of acute B-cell leukaemia induced by BCR-ABL1. Nat Genet 2000;24:57-60.
3. Schmitt CA, Fridman JS, Yang M, et al. Dissecting p53 tumor suppressor functions in vivo. Cancer Cell 2002;1:289-98.
4. Yu Y, Bradley A. Engineering chromosomal rearrangements in mice. Nat Rev Genet 2001;2:780-90.
5. Copeland NG, Jenkins NA, Court DL. Recombineering: a powerful new tool for mouse functional genomics. Nat Rev Genet 2001;2:769-79.
6. Braude P, Pickering S, Flinter F, Ogilvie CM. Preimplantation genetic diagnosis. Nat Rev Genet 2002;3:941-55.
7. Verlinsky Y, Rechitsky S, Schoolcraft W, et al. Preimplantation diagnosis for Fanconi anemia combined with HLA matching. JAMA 2001;285:3130-3.
8. Savulescu J. Education and debate: deaf lesbians, "designer disability," and the future of medicine. BMJ 2002;325:771-3.
9. Jimenez-Sanchez G, Childs B, Valle D. Human disease genes. Nature 2001;409:853-5.
10. Collins F. The human genome project. Science and Christian Belief 1999;11:99-111.
11. Hacein-Bey-Abina S, Le Deist F, Carlier F, et al. Sustained correction of X-linked severe combined immunodeficiency by ex vivo gene therapy. N Engl J Med 2002;346:1185-93.
12. Aiuti A, Slavin S, Aker M, et al. Correction of ADA-SCID by stem cell gene therapy combined with nonmyeloablative conditioning. Science 2002;296:2410-3.
13. Alexander DR. Rebuilding the matrix-science and faith in the 21st century. Oxford: Lion, 2001.